Synthesis of biologically active canine CCK-58

Regulatory Peptides

Volumn 113, Issue 1-3, 2003, Pages 71-77

  Reeve Jr , Joseph R ^a,b   Keire, David A ^a,b   Coskun, Tamer ^a,b   Green, Gary M ^c   Evans, Chris ^d   Ho, F J ^a,b   Lee, Terry D ^e   Davis, Michael T ^e   Shively, John E ^e   Solomon, Travis E ^a,b  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Amylase secretion; Cholecystokinin; Molecular forms; Pancreatic fluid secretion; Pancreatic secretion; Peptide synthesis

Indexed keywords

AMYLASE; CCK 58; CHOLECYSTOKININ OCTAPEPTIDE; CHOLECYSTOKININ OCTAPEPTIDE DERIVATIVE; CHOLECYSTOKININ RECEPTOR STIMULATING AGENT; TYROSINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG SYNTHESIS; ENZYME RELEASE; MALE; MASS SPECTROMETRY; NONHUMAN; PANCREAS; PANCREAS JUICE; PANCREAS SECRETION; PRIORITY JOURNAL; RAT; STIMULATION; SULFATION;

EID: 12444283839     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(02)00301-4     Document Type: Article

References (33)

1. Liddle R.A., Elashoff J., Reeve J.R. Jr. Relative bioactivities of cholecystokinins-8 and -33 on rat pancreatic acini. Peptides. 7:1986;723-727.
2. Solomon T.E., Yamada T., Elashoff J., Wood J., Beglinger C. Bioactivity of cholecystokinin analogues: CCK-8 is not more potent than CCK-33. Am. J. Physiol. 247:1984;G105-G111.
3. Calam J., Ellis A., Dockray G.J. Identification and measurement of molecular variants of cholecystokinin in duodenal mucosa and plasma. Diminished concentrations in patients with celiac disease. J. Clin. Invest. 69:1982;218-225.
4. Liddle R.A., Goldfine I.D., Williams J.A. Bioassay of plasma cholecystokinin in rats: effects of food, trypsin inhibitor, and alcohol. Gastroenterology. 87:1984;542-549.
5. Kothary P.C., Vinik A.I., Owyang C., Fiddian-Green R.G. Immunochemical studies of molecular heterogeneity of cholecystokinin in duodenal perfusates and plasma in humans. J. Biol. Chem. 258:1983;2856-2863.
6. Walsh J.H., Lamers C.B., Valenzuela J.E. Cholecystokinin-octapeptidelike immunoreactivity in human plasma. Gastroenterology. 82:1982;438-444.
7. Rehfeld J.F., Holst J.J., Jensen S.L. The molecular nature of vascularly released cholecystokinin from the isolated perfused porcine duodenum. Regul. Pept. 3:1982;15-28.
8. Eberlein G.A., Eysselein V.E., Hesse W.H., Goebell H., Schaefer M., Reeve J.R. Jr. Detection of cholecystokinin-58 in human blood by inhibition of degradation. Am. J. Physiol. 253:1987;G477-G482.
9. Rehfeld J.F., Sun G., Christensen T., Hillingso J.G. The predominant cholecystokinin in human plasma and intestine is cholecystokinin-33. J. Clin. Endocrinol. Metab. 86:2001;251-258.
10. Eysselein V.E., Eberlein G.A., Hesse W.H., Singer M.V., Goebell H., Reeve J.R. Jr. Cholecystokinin-58 is the major circulating form of cholecystokinin in canine blood. J. Biol. Chem. 262:1987;214-217.
11. Tatemoto K., Jornvall H., Siimesmaa S., Hallden G., Mutt V. Isolation and characterization of cholecystokinin-58 (CCK-58) from porcine brain. FEBS Lett. 174:1984;289-293.
12. Fuxe K., Agnati L.F., Vanderhaeghen J.J., Tatemoto K., Andersson K., Eneroth P.et al. Cholecystokinin neuron systems and their interactions with the presynaptic features of the dopamine neuron systems. A morphometric and neurochemical analysis involving studies on the action of cholecystokinin-8 and cholecystokinin-58. Ann. N.Y. Acad. Sci. 448:1985;231-254.
13. Reeve J.R. Jr., Eysselein V.E., Rosenquist G., Zeeh J., Regner U., Ho F.J.et al. Evidence that CCK-58 has structure that influences its biological activity. Am. J. Physiol. 270:1996;G860-G868.
14. Reeve J.R. Jr., McVey D.C., Bunnett N.W., Solomon T.E., Keire D.A., Ho F.J.et al. Differences in receptor binding and stability to enzymatic digestion between CCK-8 and CCK-58. Pancreas. 25:2002;e50-e55.
15. Davis M.T., Stahl D.C., Lee T.D. Low flow high-performance liquid chromatography solvent delivery system designed for tandem capillary liquid chromatography-mass spectrometry. J. Am. Soc. Mass Spectrom. 6:1995;571-577.
16. Solomon T.E., Walsh J.H., Bussjaeger L., Zong Y., Hamilton J.W., Ho F.J.et al. COOH-terminally extended secretins are potent stimulants of pancreatic secretion. Am. J. Physiol. 276:1999;G808-G816.
17. Keire D.A., Solomon T.E., Reeve J.R. Jr. NMR evidence for different conformations of the bioactive region of rat CCK-8 and CCK-58. Biochem. Biophys. Res. Commun. 293:2002;1014-1020.
18. Reeve J.R. Jr., Eysselein V., Walsh J.H., Ben-Avram C.M., Shively J.E. New molecular forms of cholecystokinin. Microsequence analysis of forms previously characterized by chromatographic methods. J. Biol. Chem. 261:1986;16392-16397.
19. Eysselein V.E., Reeve J.R. Jr., Shively J.E., Miller C., Walsh J.H. Isolation of a large cholecystokinin precursor from canine brain. Proc. Natl. Acad. Sci. U. S. A. 81:1984;6565-6568.
20. Yamamoto M., Reeve J.R. Jr., Green G.M. CCK extended structure markedly influences pancreatic secretion in conscious rats. Digestion. 60:1999;409.
21. Folsch U.R., Creutzfeldt W. Pancreatic duct cells in rats: secretory studies in response to secretin, cholecystokinin-pancreozymin, and gastrin in vivo. Gastroenterology. 73:1977;1053-1059.
22. de Ondarza J., Hootman S.R. Regulation of cyclic AMP levels in guinea pig pancreatic ducts and cultured duct epithelial monolayers. Pancreas. 11:1995;261-270.
23. Stuenkel E.L., Hootman S.R. Secretagogue effects on intracellular calcium in pancreatic duct cells. Pflügers Arch. 416:1990;652-658.
24. Smith J.P., Yelamarty R.V., Kramer S.T., Cheung J.Y. Effects of cholecystokinin on cytosolic calcium in pancreatic duct segments and ductal cells. Am. J. Physiol. 264:1993;G1177-G1183.
25. Li Y., Hao Y., Owyang C. High-affinity CCK-A receptors on the vagus nerve mediate CCK-stimulated pancreatic secretion in rats. Am. J. Physiol. 273:1997;G679-G685.
26. Williams J.A., Korc M., Dormer R.L. Action of secretagogues on a new preparation of functionally intact, isolated pancreatic acini. Am. J. Physiol. 235:1978;517-524.
27. Guan D., Ohta H., Tawil T., Spannagel A.W., Liddle R.A., Green G.M. Lack of cholinergic control in feedback regulation of pancreatic secretion in the rat. Gastroenterology. 98:1990;437-443.
28. Kreis M.E., Zittel T.T., Raybould H.E., Reeve J.R. Jr., Grundy D. Prolonged intestinal afferent nerve discharge in response to cholecystokinin-58 compared to cholecystokinin-8 in rats. Neurosci. Lett. 230:1997;89-92.
29. Keire D.A., Solomon T.E., Reeve J.R. Jr. Identical primary sequence but different conformations of the bioactive regions of canine CCK-8 and CCK-58. Biochem. Biophys. Res. Commun. 266:1999;400-404.
30. Turkelson C.M., Reeve J.R. Jr., Solomon T.E. Low immunoreactivity of canine cholecystokinin-58. Gastroenterology. 99:1990;646-651.
31. Fuhlendorff J., Johansen N.L., Melberg S.G., Thogersen H., Schwartz T.W. The antiparallel pancreatic polypeptide fold in the binding of neuropeptide Y to Y1 and Y2 receptors. J. Biol. Chem. 265:1990;11706-11712.
32. Keire D.A., Mannon P., Kobayashi M., Walsh J.H., Solomon T.E., Reeve J.R. Jr. Primary structures of PYY, [Pro(34)]PYY, and PYY-(3-36) confer different conformations and receptor selectivity. Am. J. Physiol. 279:2000;G126-G131.
33. Keire D.A., Bowers C.W., Solomon T.E., Reeve J.R. Jr. Structure and receptor binding of PYY analogs. Peptides. 23:2002;305-321.